Nanofractionation platform with parallel mass spec to ID cytochrome CYP1A2 inhibitors

December 21, 2017

A new (and freely available) original research article by Barbara M. Zietek et al., now available ahead-of-print at SLAS Discovery Online, presents a fast, robust and accurate methodology for correlating compound identity to CYP1A2 potency of inhibitors in metabolic mixtures.

The methodology is centered around an at-line nanofractionation platform in which a metabolic mixture is chromatographically separated followed by parallel on-line mass spectrometric (MS) analysis and at-line nanofractionation on high-density microtiter well plates that are then directly exposed to a bioassay.

Correlation of reconstructed bioactivity chromatograms with MS data allows direct identification of compounds with inhibitory properties toward CYP1A2 enzymes, indicating CYP-involved drug-drug interactions. In a similar fashion, the methodology can be implemented in assaying metabolic mixtures for other CYPs relevant in drug discovery. Next to traditional Met-ID metabolic profiling, the approach presented in this new article provides direct profiles of the relative contribution of each metabolite to the assayed activity, in this case CYP1A2 inhibition.

Drug-drug interactions caused by inhibition of CYP450 enzymes (or CYPs) can lead to serious adverse reactions in patients. These inhibitory properties can be exhibited by parent compounds and by their metabolites. Together, the properties of one or more metabolites can outweigh the benefits of a drug candidate, thus leading to its failure in the drug development phase or removal from the pharmaceutical market after introduction.

In recent years, increases in drug (candidate) attrition is especially seen in the later stages of drug development. This process can be improved by implementing new screening methods that rapidly assess the biological/biochemical properties and correlate them directly to compound identities. This can rapidly deliver profiles of pharmacokinetic properties of a drug and its metabolites together with their biological properties and can be achieved by the methodology presented in this article.
-end-
Visit SLAS Discovery OnlineFirst at http://journals.sagepub.com/doi/full/10.1177/2472555217746323 to read Nanofractionation Platform with Parallel Mass Spectrometry for Identification of Cytochrome CYP1A2 Inhibitors in Metabolic Mixtures for free. SLAS Discovery is one of two MEDLINE-indexed scientific journals published by SLAS. For more information about SLAS and its journals, visit http://www.slas.org/journals.

A PDF of this article is available to credentialed media outlets upon request. Contact nhallock@slas.org.

About our Society and Journals

SLAS (Society for Laboratory Automation and Screening) is an international community of nearly 20,000 professionals and students dedicated to life sciences discovery and technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.

SLAS DISCOVERY: 2016 Impact Factor 2.444. Editor-in-Chief Robert M. Campbell, Ph.D., Eli Lilly and Company, Indianapolis, IN (USA). SLAS Discovery (Advancing Life Sciences R&D) was previously published (1996-2016) as the Journal of Biomolecular Screening (JBS).

SLAS TECHNOLOGY: 2016 Impact Factor 2.850. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore). SLAS Technology (Translating Life Sciences Innovation) was previously published (1996-2016) as the Journal of Laboratory Automation (JALA).

Follow SLAS on Twitter at @SLAS_Org.

Follow SLAS on Facebook at SocietyforLaboratoryAutomationandScreening.

Follow SLAS on YouTube at SLASvideo.

Follow SLAS Americas on LinkedIn at Society for Laboratory Automation and Screening (SLAS Americas).

Follow SLAS Europe on LinkedIn at Society for Laboratory Automation and Screening Europe (SLAS Europe).

SLAS (Society for Laboratory Automation and Screening)

Related Enzymes Articles from Brightsurf:

Bacilli and their enzymes show prospects for several applications
This publication is devoted to the des­cription of different microbial enzymes with prospects for practical application.

Ancient enzymes can contribute to greener chemistry
A research team at Uppsala University has resurrected several billion-year-old enzymes and reprogrammed them to catalyse completely different chemical reactions than their modern versions can manage.

Advances in the production of minor ginsenosides using microorganisms and their enzymes
Advances in the Production of Minor Ginsenosides Using Microorganisms and Their Enzymes - BIO Integration https://bio-integration.org/wp-content/uploads/2020/05/bioi20200007.pdf Announcing a new article publication for BIO Integration journal.

Cold-adapted enzymes can transform at room temperature
Enzymes from cold-loving organisms that live at low temperatures, close to the freezing point of water, display highly distinctive properties.

How enzymes build sugar trees
Researchers have used cryo-electron microscopy to elucidate for the first time the structure and function of a very small enzyme embedded in cell membranes.

Energized by enzymes -- nature's catalysts
Scientists at Pacific Northwest National Laboratory are using a custom virtual reality app to design an artificial enzyme that converts carbon dioxide to formate, a kind of fuel.

Mathematical model reveals behavior of cellular enzymes
Mathematical modeling helps researchers to understand how enzymes in the body work to ensure normal functioning.

While promoting diseases like cancer, these enzymes also cannibalize each other
In diseases like cancer, atherosclerosis, and sickle cell anemia, cathepsins promote their propagation.

Researchers finally grasp the work week of enzymes
Scientists have found a novel way of monitoring individual enzymes as they chomp through fat.

How oxygen destroys the core of important enzymes
Certain enzymes, such as hydrogen-producing hydrogenases, are unstable in the presence of oxygen.

Read More: Enzymes News and Enzymes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.